Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel Free AKRO Stock Alerts

Akero Therapeutics (AKRO) SEC Filings & 10K Form

Akero Therapeutics logo
$45.22 -0.98 (-2.12%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$46.61 +1.39 (+3.07%)
As of 09/19/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Akero Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/12/2025
7:36 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
7:36 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
7:38 PM		Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
7:39 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
7:39 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025
6:48 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025
4:46 PM		Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
6:47 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025
8:32 PM		Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025
10:25 AM		Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
08/14/2025
7:00 AM		Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
08/13/2025
5:37 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025
5:37 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
7:32 PM		Akero Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
9:34 AM		Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
08/08/2025
6:30 AM		Akero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2025
6:37 AM		Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
5:00 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
5:30 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2025
6:00 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025
3:27 PM		Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
5:00 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
5:00 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:06 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:07 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:07 PM		Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:07 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:08 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:08 PM		Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:09 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:22 AM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:22 AM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:32 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:32 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:33 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:33 PM		Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:33 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
5:34 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
4:30 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:36 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM		Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
4:30 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:20 PM		Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
6:06 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
7:13 AM		Akero Therapeutics (Subject)
GENERAL ATLANTIC, L.P. (Filed by)
Form SCHEDULE 13G/A
05/14/2025
11:24 AM		Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/13/2025
8:11 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
5:47 PM		Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2025
9:44 AM		Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/12/2025
6:14 AM		Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
6:30 AM		Akero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
6:18 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:34 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
3:41 PM		Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2025
5:22 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
7:00 AM		Akero Therapeutics (Filer)
Form DEF 14A
04/28/2025
7:23 AM		Akero Therapeutics (Filer)
Form ARS
04/16/2025
5:00 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
5:00 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
5:00 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:24 PM		Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
6:42 PM		Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:30 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
8:18 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:24 PM		Akero Therapeutics (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:30 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:33 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
7:18 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:00 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:30 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:55 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:56 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:05 PM		Akero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
7:30 AM		Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
6:30 AM		Akero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
4:31 PM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
11:58 AM		Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM		Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/11/2025
8:30 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
6:54 PM		Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
5:05 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:03 AM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
8:14 AM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
8:14 AM		Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:52 AM		Akero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
7:43 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
7:43 PM		Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
7:43 PM		Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:08 PM		Akero Therapeutics (Filer)
Form 424B5
01/27/2025
8:35 PM		Akero Therapeutics (Subject)
Form FWP
01/27/2025
5:07 PM		Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:08 PM		Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:53 PM		Akero Therapeutics (Filer)
Form 424B5
01/27/2025
3:23 PM		Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AKRO) was last updated on 9/21/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel